Top Banner
Analysis of tumour stage and treatment •26 REGISTRIES IN TOTAL –2: BREAST ONLY –2: CHILDREN ONLY •DATE OF INCIDENCE RANGE: 1978-2003 •YEARS OF DATA RANGE: 2 TO 25 •REGISTRIES VARY IN SIZE (NUMBER OF CASES) AND YEAR RANGE OF DATA
32

Analysis of tumour stage and treatment

Jan 21, 2016

Download

Documents

Analysis of tumour stage and treatment. 26 REGISTRIES IN TOTAL 2: BREAST ONLY 2: CHILDREN ONLY DATE OF INCIDENCE RANGE: 1978-2003 YEARS OF DATA RANGE: 2 TO 25 REGISTRIES VARY IN SIZE (NUMBER OF CASES) AND YEAR RANGE OF DATA. Stage and treatment data fields. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Analysis of tumour stage and treatment

Analysis of tumour stage and treatment

•26 REGISTRIES IN TOTAL

–2: BREAST ONLY–2: CHILDREN ONLY

 

•DATE OF INCIDENCE RANGE: 1978-2003

•YEARS OF DATA RANGE: 2 TO 25

 •REGISTRIES VARY IN SIZE (NUMBER OF CASES) AND YEAR RANGE OF DATA

Page 2: Analysis of tumour stage and treatment

Stage and treatment data fields 

Method of diagnosis: histology, cytology, either, none or unknown

 Actual T, N and M data: detailed information on T, N and M status Condensed T, N and M: (more generalised information)

T: localised or advanced N: none or present M: none or present Stage (Extent of Disease) combined information on tumour, nodal & distant metastasis in a single value.

* possible to assign cases as local, regional or distant Tumour size in millimetres Number of nodes examined & number with metastasis Certainty factor: if specialised diagnostic methods were used in order to stage Treatment surgery, chemotherapy, radiotherapy, other therapies

(such as hormonal therapy) indicated (yes, no, unknown)

Treatment flagged as first therapy post-diagnosis and/or symptomatic treatment

Page 3: Analysis of tumour stage and treatment

RegistryMicro

confirmation Stage (EOD) TNM StageCondensed TNM Stage

Tumour Size Nodes

Certainty factor Treatment

Amsterdam 100% 81% 60% 80% 0 0 0 0Basel 100% 0 50% 0 7% 5% 0 0Basque 93% 43% 0 0 0 0 0 21%CastillonB 96% 90% 90% 90% 85% 90% 95% 95%Cracow 90% 50% 10% 1% 1% 1% 2% 30%EAnglia 60% 30% 0 0 4% 4% 0 40%Eindhoven 95% 5 70% 60% 2% 0 0 0Finland 100% 80% 0 0 0 0 0 90%Flemish 92% 0 40% 0 0 0 0 0Geneva 90% 93% 70% 85% 30% 3% 0 0Grisons 99% 53% 85% 85% 10% 10% 0 0Ireland 97% 42% 45% 0 0 0 0 0Kielce 87% 52% 0 0 0 0 0 80%Lorraine-Child 100% 70% 70% 70% 0 0 0 0March-Child 100% 17% 2% 8% 14% 2% 16% 60%NIreland 99% 12% 15% 0 9% 8% 0 0Palermo 95% 0 90% 0 70% 80% 0 98%Saarland 99% 52% 34% 0 0 0 0 60%Slovenia 98% 91% 22% 36% 0 0 0 0St.Gallen 98% 78% 53% 50% 8% 99% 0 0Ticino 100% 54% 55% 54% 14% 25% 0 0Tyrol 95% 0 0 30% 0 0 0 40%Valais 99% 40% 63% 60% 8% 8% 0 0WestMidland 85% 100% 0 0 11% 5% 0 45%Yorkshire 100% 0 1% 0 8% 0 0 99%Zurich 99% 22% 60% 60% 7% 5% 0 0

PERCENTAGE OF ALL TUMOURS

Data available on stage and treatment

Page 4: Analysis of tumour stage and treatment

Entities examined for stage and treatment:

Digestive cancers: OesophagusStomachSmall IntestineColon, Rectum, Anal CanalPancreasLiver and Intrahepatic Bile DuctsGall-bladder and Extrahepatic Bile Ducts

Lung cancer

Breast cancer

Prostate cancer

Page 5: Analysis of tumour stage and treatment

Breast cancer: breakdown by sub-entity

BREAST CANCER Total% of all breast

cancersmicroscopically

diagnosed other/unknown

Specified as no microscopic confirmation

Total cases "Epithelial tumours of the breast" 418390 100,0% 91,5% 8,5% 4,1%

Cases not coded to sub-entity level 23598 5,6% 40,5% 59,5% 33,3%

Invasive ductal carcinoma 247888 59,2% 98,8% 1,2% 0,1%Invasive lobular carcinoma 40495 9,7% 98,1% 1,9% 0,1%Mammary Pagets disease 3001 0,7% 96,6% 3,4% 2,1%Special types of adenocarcinoma 14840 3,5% 98,5% 1,5% 0,1%Metaplastic carcinoma 85415 20,4% 80,0% 20,0% 10,5%Salivary gland type tumours 302 0,1% 90,1% 9,9% 0,0%Male breast 2851 0,7% 90,0% 10,0% 4,2%

Page 6: Analysis of tumour stage and treatment

REGISTRY Total

% of all breast cancers coded as metaplastic

carcinomamicroscopically

diagnosed other/unknown

No microscopic confirmation

EAnglia 12751 32.7% 33.5% 66.5% 12.6%Yorkshire 18804 31.2% 81.9% 18.1% 17.7%Kielce 731 29.8% 100.0% 0.0% 0.0%Cracow 1444 28.8% 99.9% 0.1% 0.0%WestMidlands 19778 28.1% 81.5% 18.5% 18.1%Slovenia 4132 25.5% 93.0% 7.0% 5.7%Saarland 2253 18.6% 96.9% 3.1% 3.0%Flemish 4395 18.1% 80.2% 19.8% 1.5%Amsterdam 4502 17.8% 100.0% 0.0% 0.0%Eindhoven 2120 16.6% 99.8% 0.2% 0.1%NorthernIreland 1370 15.7% 97.5% 2.5% 2.0%CastillonB 245 14.9% 98.8% 1.2% 1.2%Ireland 2384 14.6% 100.0% 0.0% 0.0%Geneva 800 11.9% 99.5% 0.5% 0.3%Finland 7263 11.6% 99.9% 0.1% 0.1%StGallen 412 10.9% 89.3% 10.7% 10.7%Tyrol 379 10.3% 99.2% 0.8% 0.8%Basque 1106 9.6% 82.5% 17.5% 0.2%Valais 129 9.2% 100.0% 0.0% 0.0%Zurich 34 8.4% 100.0% 0.0% 0.0%Ticino 141 8.1% 98.6% 1.4% 1.4%Grisons 66 5.3% 98.5% 1.5% 1.5%Palermo 51 4.5% 98.0% 2.0% 0.0%Basel 125 2.2% 98.4% 1.6% 1.6%

Metaplastic breast carcinoma: breakdown by Registry

Page 7: Analysis of tumour stage and treatment

Lung cancer: breakdown by sub-entity

LUNG CANCER Total% of all lung

cancersmicroscopically

diagnosed other/unknown

No microscopic confirmation

Total cases "Epithelial tumours of the lung" 419402 69,7% 30,3% 18,5%

Cases not coded to sub-entity level 159507 38,0% 29,3% 70,7% 46,1%

Squamous cell carcinoma 108196 25,8% 93,2% 6,8% 1,6%Adenocarcinoma 56282 13,4% 95,9% 4,1% 1,3%Large cell carcinoma 27119 6,5% 97,0% 3,0% 0,9%Well differentiated endocrine carcinoma 2343 0,6% 97,7% 2,3% 1,0%Poorly diff endocrine carcinoma 56107 13,4% 94,7% 5,3% 1,8%Bronchel-alveolar carcarcinoma 3207 0,8% 93,1% 6,9% 3,1%Salivary gland type tumours 272 0,1% 96,3% 3,7% 1,1%Saracomatoid carcinoma 851 0,2% 93,9% 6,1% 0,8%Undifferentiated carcinoma 5518 1,3% 92,7% 7,3% 1,1%

Page 8: Analysis of tumour stage and treatment

Large cell carcinoma of lung: breakdown by Registry

Large cell carcinoma Total

% of all lung cancers coded

as large cell carcinoma

microscopically diagnosed other/unknown

No microscopic confirmation

StGallen 769 28,5% 98,3% 1,7% 0,0%Ticino 314 26,1% 100,0% 0,0% 0,0%Basel 1073 25,1% 98,4% 1,6% 1,6%Zurich 47 24,5% 100,0% 0,0% 0,0%Saarland 2039 23,3% 99,3% 0,7% 0,7%Amsterdam 4201 20,0% 100,0% 0,0% 0,0%Eindhoven 2146 18,5% 99,5% 0,5% 0,5%Grisons 165 18,1% 98,8% 1,2% 1,2%Slovenia 2278 14,2% 99,6% 0,4% 0,3%Flemish 1865 13,0% 99,9% 0,1% 0,1%Yorkshire 5726 12,5% 98,0% 2,0% 2,0%Geneva 378 9,1% 98,7% 1,3% 0,0%Valais 86 8,6% 96,5% 3,5% 0,0%Ireland 736 8,5% 100,0% 0,0% 0,0%EAnglia 1561 7,4% 65,3% 34,7% 0,8%Basque 686 6,9% 99,4% 0,6% 0,0%Tyrol 160 6,6% 98,8% 1,3% 1,3%Kielce 231 6,2% 100,0% 0,0% 0,0%WestMid 2497 6,2% 97,4% 2,6% 2,4%NorthernIreland 77 2,0% 98,7% 1,3% 1,3%Cracow 84 1,6% 100,0% 0,0% 0,0%Finland 0 0,0% 0,0% 0,0% 0,0%

Page 9: Analysis of tumour stage and treatment

Colon cancer: Tumour T Stage validity**codes judged invalid if they do not conform to AJCC staging protocol (Edition 1-6)

Registry Total cases% of cases with

valid stagesTotal invalid

stages

% of staged cases deemed

invalidAmsterdam 15460 87.6% 0 0.0%Basel 3530 92.7% 0 0.0%Cracow 3011 3.5% 0 0.0%Eindhoven 7770 86.3% 87 1.3%Flemish 13039 48.6% 31 0.5%Geneva 3651 67.8% 311 11.2%Grisons 980 90.0% 0 0.0%Ireland 11738 82.1% 0 0.0%NorthernIreland 6638 57.9% 39 1.0%Saarland 13056 48.1% 81 1.3%Slovenia 10760 31.4% 0 0.0%StGallen 2379 74.5% 1 0.1%Ticino 1029 88.6% 0 0.0%Valais 852 89.9% 0 0.0%Yorkshire 40429 11.6% 0 0.0%Zurich 1443 91.9% 0 0.0%

Valid codes: 0, 1, 2 (2A,2B [2nd ed AJCC]), 3, 4, 5 ([1st ed AJCC])

Page 10: Analysis of tumour stage and treatment

Colon cancer: Distribution of tumour T stage

Tumour T stage

0,0%

10,0%

20,0%

30,0%

40,0%

50,0%

60,0%

70,0%

80,0%

90,0%

100,0%A

mst

erda

m

Bas

el

Cra

cow

Ein

dhov

en

Fle

mis

h

Gen

eva

Gris

ons

Irel

and

Nor

ther

nIre

land

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Yor

kshi

re

Zur

ich

per

cen

t o

f to

tal v

alid

sta

ged

tu

mo

urs

T4

T3

T2

T1

T0/IS

Average (all registries excl Ireland & Zurich): T1=7%, T2=15%, T3=60%, T4=18%)

Page 11: Analysis of tumour stage and treatment

Breast cancer: Distribution of tumour T stage

Tumour T stage

0,0%

10,0%

20,0%

30,0%

40,0%

50,0%

60,0%

70,0%

80,0%

90,0%

100,0%A

mst

erda

m

Bas

el

Cas

tillo

nB

Cra

cow

Ein

dhov

en

Fle

mis

h

Gen

eva

Gris

ons

Irel

and

Nor

ther

nIre

land

Pal

erm

o

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Zur

ich

per

cen

t o

f to

tal v

alid

sta

ged

tu

mo

urs

T4

T3

T2

T1

T0/IS

Average (all registries excl Ireland): T1=52%, T2=35%, T3=5%, T4=8%)

Page 12: Analysis of tumour stage and treatment

Registry Total cases% of all cases

staged invalid stages

% of staged cases deemed

invalidBasel 3530 88.8% 35 1.1%Zurich 1443 86.2% 0 0.0%Grisons 980 85.5% 0 0.0%StGallen 2379 84.1% 0 0.0%Valais 852 82.6% 0 0.0%Ticino 1029 81.2% 0 0.0%Eindhoven 7770 78.2% 27 0.4%Ireland 11738 73.3% 0 0.0%Geneva 3651 71.3% 20 0.8%Amsterdam 15460 70.7% 0 0.0%NorthernIreland 6638 51.1% 0 0.0%Saarland 13056 46.3% 0 0.0%Flemish 13039 40.0% 0 0.0%Slovenia 10760 31.1% 0 0.0%Yorkshire 40429 11.4% 0 0.0%Cracow 3011 3.5% 0 0.0%

Colon cancer: Tumour N Stage validity**codes judged invalid if they do not conform to AJCC staging protocol (Edition 1-6)

Valid codes: 0, 1, 2, 3

Page 13: Analysis of tumour stage and treatment

Colon cancer: Distribution of tumour N stage

Tumour N Stage

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Slo

veni

a

StG

alle

n

Gen

eva

Gris

ons

Bas

el

Ein

dhov

en

Zur

ich

Irel

and

Tic

ino

Yor

kshi

re

Val

ais

Fle

mis

h

Saa

rland

Am

ster

dam

Nor

ther

nIre

land

Cra

cow

per

cen

t o

f va

lid s

tag

es

N3

N2

N1

N0

Average (all registries excl Slovenia Cracow, Zurich, Ireland): N0=54%, N1=30%, N2=13%, N3=3%)

Page 14: Analysis of tumour stage and treatment

Colon cancer: Distribution of tumour M stage

Average all registries: M0=71%, M1=29%

Tumour M stage (proportion of staged cases)

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%A

mst

erda

m

Bas

el

Cra

cow

Ein

dhov

en

Fle

mis

h

Gen

eva

Gris

ons

Irel

and

Nor

ther

nIre

land

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Yor

kshi

re

per

cen

t o

f va

lid s

tag

es

M1

M0

Page 15: Analysis of tumour stage and treatment

Colon cancer: Distribution of tumour M stage

Tumour M stage (proportion of all cases)

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%A

mst

erda

m

Bas

el

Cra

cow

Ein

dhov

en

Fle

mis

h

Gen

eva

Gris

ons

Irel

and

Nor

ther

nIre

land

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Yor

kshi

re

per

cen

t o

f to

tal

MX

M1

M0

Page 16: Analysis of tumour stage and treatment

Summary stage (extent of disease)

• 1: Tumour confined to site of origin

• 2: Tumour has spread to immediately adjacent tissues and /or regional lymph nodes

• 3: Tumour has spread to distant organs

• 4: Tumour not confined to site of origin but not specified whether code 2 or 3 applies

• 5: No distant metastasis but not specified whether code 1 or 2 applies

Codes can be grouped to define a tumour as:Local (code 1)Regional (code 5+2)Distant (code 4+3)

ORDER: 1-5-2-4-3

Page 17: Analysis of tumour stage and treatment

Stage (Extent of disease) for Breast cancer

Registry Stage 1 Stage 2 Stage 3 Stage 4 Stage 5% of all staged Total cases

WestMidlands 19728 22420 4549 26577 100,0% 73274Geneva 3294 2372 432 128 281 95,6% 6507Amsterdam 13517 10226 1526 109 98,8% 25378Eindhoven 37 48 84 1,4% 12162Eindhoven-gen 4873 4245 638 667 182 87,2% 10605Slovenia 7110 7480 1713 96,8% 16303StGallen 1113 906 330 624 331 86,7% 3304Ticino 640 497 111 167 33 82,6% 1448Ireland 3658 3472 1152 2904 452 71,7% 11638Finland 33867 20664 3474 894 90,7% 58899Valais 103 642 50,8% 745Grisons 114 496 46,3% 610Eanglia 12291 3633 2099 14232 88,0% 32255Saarland 4179 4893 1255 17 65,2% 10344Kielce 504 497 251 43,8% 1252Cracow 1570 1940 1239 222 75,9% 4971NorthernIreland 3017 2446 62 34 62,7% 5559Basque 2777 1877 299 40,6% 4953Zurich 114 27,9% 1443

Page 18: Analysis of tumour stage and treatment

Stage (Extent of disease) for Breast cancer

Registry Stage 1 Stage 2 Stage 3 Stage 4 Stage 5WestMidlands 26,9% 30,6% 6,2% 36,3%Geneva 50,6% 36,5% 6,6% 2,0% 4,3%Amsterdam 53,3% 40,3% 6,0% 0,4%Eindhoven 21,9% 28,4% 49,7%Eindhoven-gen 46,0% 40,0% 6,0% 6,3% 1,7%Slovenia 43,6% 45,9% 10,5%StGallen 33,7% 27,4% 10,0% 18,9% 10,0%Ticino 44,2% 34,3% 7,7% 11,5% 2,3%Ireland 31,4% 29,8% 9,9% 25,0% 3,9%Finland 57,5% 35,1% 5,9% 1,5%Valais 13,8% 86,2%Grisons 18,7% 81,3%Eanglia 38,1% 11,3% 6,5% 44,1%Saarland 40,4% 47,3% 12,1% 0,2%Kielce 40,3% 39,7% 20,0%Cracow 31,6% 39,0% 24,9% 4,5%NorthernIreland 54,3% 44,0% 1,1% 0,6%Basque 56,1% 37,9% 6,0%Zurich 100,0%

Page 19: Analysis of tumour stage and treatment

Stage (Extent of disease) for Breast cancer

Breast cancer: distribution of tumour overall stage

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Am

ster

dam

Bas

que

Cas

tillo

nB

Cra

cow

Ean

glia

Ein

dhov

en

Ein

dhov

en-g

en

Fin

land

Gen

eva

Gris

ons

Irel

and

Kie

lce

Nor

ther

nIre

land

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Wes

tMid

perc

ent o

f sta

ged

tum

ours

stage 3

stage 4

stage 2

stage 5

stage 1

Stages separately

Page 20: Analysis of tumour stage and treatment

Stage (Extent of disease) for Breast cancerGrouped stages

Breast cancer: distribution of tumour overall stage

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Am

ster

dam

Bas

que

Cas

tillo

nB

Cra

cow

Ean

glia

Ein

dhov

en

Ein

dhov

en-g

en

Fin

land

Gen

eva

Gris

ons

Irel

and

Kie

lce

Nor

ther

nIre

land

Saa

rland

Slo

veni

a

StG

alle

n

Tic

ino

Val

ais

Wes

tMid

perc

ent o

f sta

ged

tum

ours

distant

regional

local

Page 21: Analysis of tumour stage and treatment

Registry total TanyN0M0 Stage=1 TXN0M0 Stage=1Amsterdam 25692 44,1% 53,3% 58,3% 98,8%CastillonB 1579 61,2% 53,7% 70,3% 95,0%Cracow 6551 57,2% 31,6% 27,8% 75,9%Eindhoven 12162 54,9% 21,9% 78,5% 1,4%Eindhoven-generated 12162 54,9% 46,0% 78,5% 87,2%Geneva 6805 57,3% 50,6% 81,7% 95,6%Grisons 1318 54,4% 0,0% 65,9% 46,3%Ireland 16223 48,5% 31,4% 47,7% 71,7%NorthernIreland 8860 52,5% 54,3% 5,9% 62,7%Saarland 15856 53,6% 40,4% 41,6% 65,2%Slovenia 16849 57,8% 43,6% 26,9% 96,8%StGallen 3810 63,6% 33,7% 47,8% 86,7%Ticino 1752 54,6% 44,2% 68,1% 82,6%Valais 1467 53,8% 0,0% 48,8% 50,8%

% staged cases % of data with valid codes

Comparison of Stage 1 (tumour confined to site of origin) and TNM data (T=any, N=0, M=0)Breast cancer

Page 22: Analysis of tumour stage and treatment

Registry Total cases M=M1 Stage=3 M=M1 Stage=3Amsterdam 25 692 8,2% 6,0% 70,2% 98,8%CastillonB 1 579 8,7% 6,9% 75,9% 95,0%Cracow 6 551 1,2% 24,9% 27,8% 75,9%Eindhoven 12 162 6,4% 49,7% 81,8% 1,4%Eindhoven-generated 12 162 6,4% 6,0% 81,8% 87,2%Geneva 6 805 7,1% 6,6% 84,9% 95,6%Grisons 1 318 12,0% 18,7% 71,9% 46,3%Ireland 16 223 13,2% 9,9% 53,8% 71,7%NorthernIreland 8 860 10,4% 1,1% 6,7% 62,7%Saarland 15 856 11,8% 12,1% 46,0% 65,2%Slovenia 16 849 6,9% 10,5% 28,0% 96,8%StGallen 3 810 12,2% 10,0% 70,8% 86,7%Ticino 1 752 8,7% 7,7% 73,1% 82,6%Valais 1 467 13,2% 13,8% 53,4% 50,8%

% staged cases % of data with valid codes

Comparison of Stage 3 (tumour spread to distant organs) and M=1 (positive M stage) dataBreast cancer

Page 23: Analysis of tumour stage and treatment

Stage (Extent of disease) for Prostate cancer

Registry Stage 1 Stage 2 Stage 3 Stage 4 Stage 5% of all staged Total cases

WestMidlands 785 342 5000 33307 100.0% 39434Amsterdam 10421 1083 3005 204 94.7% 15532Geneva 1204 751 730 111 974 91.2% 4132Slovenia 3733 892 1272 79.6% 7409Grisons-gen 234 154 195 91 177 75.8% 1123StGallen 1026 564 579 304 529 74.5% 4028Eindhoven-gen 1429 554 976 167 1156 74.3% 5760Finland 20862 597 8232 1701 65.9% 47643Cracow 144 418 142 145 48.7% 1743Ticino 162 153 126 84 17 48.4% 1120Ireland 657 574 2096 596 2299 47.1% 13200Grisons 195 245 39.2% 1123Basque 1545 224 610 34.5% 6905Eanglia 4884 766 2179 34.4% 22753Kielce 270 106 218 32.5% 1826Valais 138 202 29.0% 1171Saarland 1430 369 689 16 26.3% 9519Basel-gen 390 125 168 419 126 26.2% 4680Flemish-gen 1304 737 881 2245 392 25.8% 21519

Page 24: Analysis of tumour stage and treatment

Stage (Extent of disease) for Prostate cancer

Registry Stage 1 Stage 2 Stage 3 Stage 4 Stage 5WestMidlands 2,0% 0,9% 12,7% 84,5%Amsterdam 70,8% 7,4% 20,4% 1,4%Geneva 31,9% 19,9% 19,4% 2,9% 25,8%Slovenia 63,3% 15,1% 21,6%Grisons-gen 27,5% 18,1% 22,9% 10,7% 20,8%StGallen 34,2% 18,8% 19,3% 10,1% 17,6%Eindhoven-gen 33,4% 12,9% 22,8% 3,9% 27,0%Finland 66,5% 1,9% 26,2% 5,4%Cracow 17,0% 49,2% 16,7% 17,1%Ticino 29,9% 28,2% 23,2% 15,5% 3,1%Ireland 10,6% 9,2% 33,7% 9,6% 36,9%Grisons 44,3% 55,7%Basque 64,9% 9,4% 25,6%Eanglia 62,4% 9,8% 27,8%Kielce 45,5% 17,8% 36,7%Valais 40,6% 59,4%Saarland 57,1% 14,7% 27,5% 0,6%Basel-gen 31,8% 10,2% 13,7% 34,1% 10,3%Flemish-gen 23,5% 13,3% 15,8% 40,4% 7,1%

Page 25: Analysis of tumour stage and treatment

Breast cancer: Registries where lymph node status was examined

Registry Total % of cases examined% of examined cases with positive nodes

conflict between N stage & Nodal mets

StGallen 3810 99,7% 23,2% 66 (1.7%)CastillonB 1579 92,1% 43,4%Palermo 1169 82,1% 47,7% 1 (0.1%)Ticino 1752 75,2% 45,1%NorthernIreland 8860 63,4% 55,5% 13 (0.1%)Zurich 408 51,2% 43,7%Grisons 1318 36,1% 42,8%Valais 1467 33,7% 41,7%Geneva 6805 33,1% 35,0%Basel 5752 32,7% 55,5% 7 (0.1%)WestMid 73274 29,3% 41,5%Eanglia 36636 17,1% 40,0%Cracow 6551 5,1% 52,3% 3 (<0.1%)

Page 26: Analysis of tumour stage and treatment

Tumour size

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

0 1-19 20-39 40-59 60-79 80+

% o

f al

l sez

ed t

um

ou

rs

Eanglia (7.3%)

Geneva (92.4%)

NorthernIreland (25.6%)

WestMidlands (15.4%)

Yorkshire (6.7%)

Breast cancer: tumour size

Registry T1 T2 T3 T4Eanglia - - - -Geneva 51.6% 33.5% 4.3% 10.1%NorthernIreland 52.8% 38.6% 4.5% 3.8%WestMidlands - - - -Yorkshire 50.0% 42.5% 6.6% 0.8%

Tumour T Stage

Page 27: Analysis of tumour stage and treatment

Registries that provided treatment information and years of data available

year range number year range numberYorkshire 1978-2002 25 1978-2002 25Finland 1978-2002 25 1978-2002 25Kielce 1995-2002 8 1995-2002 8Saarland 1978-2002 25 1978-2002 25WestMidlands 1978-2002 25 1978-2002 25EAnglia 1978-2002 25 1992-2002 11Tyrol 1988-1999 12 1995-1999 5Basque 1986-1999 14 1995-1999 5Cracow 1978-2002 25 1996-2002 7Castillon 1995-2002 8 1995-2002 8Palermo 1999-2000 2 1999-2000 2

Case Data Treatment Data

1996-1999 common to all

Basque, EAnglia, WestMidlands: Codes = Yes - UnknownAll Other registries: Codes = Yes - No - Unknown

Page 28: Analysis of tumour stage and treatment

1996 – 1999 Lung cancer treatmentSurgery

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Yor

kshi

re

Fin

land

Kie

lce

Saa

rland

Tyr

ol

Cra

cow

Wes

tMid

Ean

glia

Bas

que

% o

f all

case

s

Yes No Unknow n

Chemotherapy

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Yor

kshi

re

Fin

land

Kie

lce

Saa

rland

Tyr

ol

Cra

cow

Wes

tMid

Ean

glia

Bas

que

% o

f all

case

s

Yes No Unknow n

Radiotherapy

0,0%

20,0%

40,0%

60,0%

80,0%

100,0%

Yor

kshi

re

Fin

land

Kie

lce

Saa

rland

Tyr

ol

Cra

cow

Wes

tMid

Ean

glia

Bas

que

% o

f all

case

s

Yes No Unknow n

Page 29: Analysis of tumour stage and treatment

Lung cancer cases having had surgery 1996-1999

RegistryTotal surgical

cases

Total microscopically

confirmed %Tyrol 302 300 99.3%Basque 1848 1816 98.3%Saarland 812 793 97.7%Eanglia 773 752 97.3%Kielce 347 335 96.5%WestMid 1435 1385 96.5%Finland 1594 1530 96.0%Cracow 343 325 94.8%Yorkshire 2192 1983 90.5%

% chemotherapy

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

Yor

kshi

re

Fin

land

Kie

lce

Saa

rland

Wes

tMid

Ean

glia

Tyr

ol

Bas

que

Cra

cow

perc

ent

of c

ases

Yorkshire: 200 cases not microscopically confirmed

Page 30: Analysis of tumour stage and treatment

Pancreas cancer cases having had surgery 1996-1999

RegistryTotal surgical

casesTotal microscopically

confirmed %Saarland 159 146 91.8%Finland 1131 908 80.3%Tyrol 115 92 80.0%Basque 266 202 75.9%WestMid 245 185 75.5%Yorkshire 250 165 66.0%Cracow 78 50 64.1%Kielce 192 114 59.4%Eanglia 630 262 41.6%

EAnglia: 368 cases not microscopically confirmed

Page 31: Analysis of tumour stage and treatment

Yorkshire: Colon cancer surgery

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

% o

f to

tal c

ases

had surgery no surgery

Finland: Colon cancer surgery

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

% o

f to

tal c

ases

had surgery no surgery

Colon Cancer: Surgery 1978-2002

Page 32: Analysis of tumour stage and treatment

Saarland: Colon cancer surgery

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

% o

f to

tal c

ases

had surgery no surgery

WestMidlands: Colon cancer surgery

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

% o

f to

tal c

ases

had surgery

Colon Cancer: Surgery 1978-2002